New Jersey S 2212: "Prescription Drug Consumer Transparency Act."

Status: Introduced in the Senate, Referred to Senate Commerce Committee (as of 2020-03-16)

State: New Jersey · Session: 219 · Bill: S 2212

Subjects: CONSUMER AFF, PHARMACEUTIC

Sponsors: Gopal, Vin, Greenstein, Linda R.

View New Jersey S 2212 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.